These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12641022)

  • 1. Influence of stent design and deployment technique on neointima formation and vascular remodeling.
    König A; Schiele TM; Rieber J; Theisen K; Mudra H; Klauss V
    Z Kardiol; 2002; 91 Suppl 3():98-102. PubMed ID: 12641022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stent design related neointimal tissue proliferation in human coronary arteries; an intravascular ultrasound study.
    Hoffmann R; Jansen C; König A; Haager PK; Kerckhoff G; vom Dahl J; Klauss V; Hanrath P; Mudra H
    Eur Heart J; 2001 Nov; 22(21):2007-14. PubMed ID: 11603908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.
    Dussaillant GR; Mintz GS; Pichard AD; Kent KM; Satler LF; Popma JJ; Wong SC; Leon MB
    J Am Coll Cardiol; 1995 Sep; 26(3):720-4. PubMed ID: 7642865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue proliferation within and surrounding Palmaz-Schatz stents is dependent on the aggressiveness of stent implantation technique.
    Hoffmann R; Mintz GS; Mehran R; Kent KM; Pichard AD; Satler LF; Leon MB
    Am J Cardiol; 1999 Apr; 83(8):1170-4. PubMed ID: 10215278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental evaluation of a short transitional edge protection balloon for intracoronary stent deployment.
    Carter AJ; Lee DP; Suzuki T; Bailey L; Lansky A; Jones R; Virmani R
    Catheter Cardiovasc Interv; 2000 Sep; 51(1):112-9. PubMed ID: 10973033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of high pressure vs low pressure stent implantation on intimal hyperplasia and follow-up lumen dimensions; results of a randomized trial.
    Hoffmann R; Haager P; Mintz GS; Kerckhoff G; Schwarz R; Franke A; vom Dahl J; Hanrath P
    Eur Heart J; 2001 Nov; 22(21):2015-24. PubMed ID: 11603909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy.
    Sera F; Awata M; Uematsu M; Kotani J; Nanto S; Nagata S
    JACC Cardiovasc Interv; 2009 Oct; 2(10):989-94. PubMed ID: 19850260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent design-related coronary artery remodeling and patterns of neointima formation following self-expanding and balloon-expandable stent implantation.
    König A; Schiele TM; Rieber J; Theisen K; Mudra H; Klauss V
    Catheter Cardiovasc Interv; 2002 Aug; 56(4):478-86. PubMed ID: 12124956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation.
    Radke PW; Figulla HR; Drexler H; Klues HG; Mügge A; Silber S; Daniel W; Schmeisser A; Reifart N; Motz W; Büttner HJ; Fischer D; Ortlepp JR; Schaefers K; Hoffmann R; Hanrath P;
    Am Heart J; 2006 Oct; 152(4):761.e1-6. PubMed ID: 16996855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound.
    Degertekin M; Regar E; Tanabe K; Lemos P; Lee CH; Smits P; de Feyter P; Bruining N; Sousa E; Abizaid A; Ligthart J; Serruys PW
    Am J Cardiol; 2003 May; 91(9):1046-50. PubMed ID: 12714144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of coronary stent overexpansion on lumen size and intimal hyperplasia at follow-up.
    Kuriyama N; Kobayashi Y; Kuroda N; Desai K; Yamamoto Y; Komiyama N; Komuro I; Fitzgerald PJ
    Am J Cardiol; 2002 Jun; 89(11):1297-9. PubMed ID: 12031732
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of zotarolimus-eluting stents with sirolimus-eluting and paclitaxel-eluting stents: intimal hyperplasia and vascular changes assessed by volumetric intravascular ultrasound analysis.
    Kang SJ; Mintz GS; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):139-45. PubMed ID: 21364151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological and quantitative analysis of vascular wall and neointimal hyperplasia after coronary stenting: comparison of bare-metal and sirolimus-eluting stents using optical coherence tomography.
    Goto I; Itoh T; Kimura T; Fusazaki T; Matsui H; Sugawara S; Komuro K; Nakamura M
    Circ J; 2011; 75(7):1633-40. PubMed ID: 21628836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of endovascular stent strut geometry on vascular injury, myointimal hyperplasia, and restenosis.
    Sullivan TM; Ainsworth SD; Langan EM; Taylor S; Snyder B; Cull D; Youkey J; Laberge M
    J Vasc Surg; 2002 Jul; 36(1):143-9. PubMed ID: 12096272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
    Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
    Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segmental vessel wall shear stress and neointimal formation after sirolimus-eluting stent implantation: physiological insights in a porcine coronary model.
    Carter AJ; Wei W; Gibson L; Collingwood R; Tio F; Dooley J; Kopia GA
    Cardiovasc Revasc Med; 2005; 6(2):58-64. PubMed ID: 16263360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose rate intracoronary radiation for inhibition of neointimal formation in the stented and balloon-injured porcine models of restenosis: angiographic, morphometric, and histopathologic analyses.
    Mazur W; Ali MN; Khan MM; Dabaghi SF; DeFelice CA; Paradis P; Butler EB; Wright AE; Fajardo LF; French BA; Raizner AE
    Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):777-88. PubMed ID: 8960503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.